Misplaced Pages

#796203

81-445: Transcutaneous electrical nerve stimulation is a commonly used treatment approach to alleviate acute and chronic pain by reducing the sensitization of dorsal horn neurons , elevating levels of gamma-aminobutyric acid and glycine , and inhibiting glial activation. Many systematic reviews and meta-analyses assessing clinical trials looking at the efficacy of TENS for different sources of pain, however, have been inconclusive due to

162-544: A 70% reduction of incontinence episode frequency, on average. Approximately 1 in 4 patients experience complete dryness while taking oxybutynin. Therefore, medication management alone is sufficient for a substantial minority, but not the majority, of patients with overactive bladder. Botulinum toxin A (Botox) is approved by the Food and Drug Administration in adults with neurological conditions, including multiple sclerosis and spinal cord injury . Botulinum Toxin A injections into

243-482: A common treatment option for people with overactive bladder syndrome. A number of antimuscarinic drugs (e.g., darifenacin , hyoscyamine , oxybutynin , tolterodine , solifenacin , trospium , fesoterodine ) are frequently used to treat overactive bladder. Long term use, however, has been linked to dementia . β3 adrenergic receptor agonists (e.g., mirabegron , vibegron ) may be used, as well. Patients taking oxybutynin and other anticholinergic drugs experience

324-478: A cystoplasty, involves the enlargement of the bladder using tissue taken from the patient's ileum , which is part of the small intestine. This procedure is rarely performed, and is only done for patients who have proven resistant to all other forms of treatment. This procedure can greatly enlarge urine volume in the bladder. Because overactive bladder is most commonly associated with aging, the majority of patients experience symptoms (with or without incontinence) for

405-400: A frequent and urgent need to urinate. Overactive bladder affects approximately 11% of the population and more than 40% of people with overactive bladder have incontinence. Conversely, about 40% to 70% of urinary incontinence is due to overactive bladder. Overactive bladder is not life-threatening, but most people with the condition have problems for years. The cause of overactive bladder

486-590: A lack of high-quality and unbiased evidence. Potential benefits of TENS treatment include its safety profile, relative affordability, ease of self-administration, and availability over-the-counter without a prescription. In principle, an adequate intensity of stimulation is necessary to achieve pain relief with TENS. An analysis of treatment fidelity—meaning that the delivery of TENS in a trial was in accordance with current clinical advice, such as using "a strong but comfortable sensation" and suitable, frequent treatment durations—showed that higher-fidelity trials tended to have

567-425: A last resort if all other treatment options fail, invasive surgical procedures may be performed. Behavioral and lifestyle changes are commonly recommended as the first-line option for treating overactive bladder. These include bladder training, which involves scheduled voiding (urination) and gradually increasing the time between bathroom visits. Pelvic floor exercises, known as Kegel exercises , can help strengthen

648-406: A non-pharmacological alternative to analgesics in the management of knee osteoarthritis pain. There is tentative evidence that TENS may be useful for painful diabetic neuropathy . As of 2015, the efficacy of TENS for phantom limb pain is unknown; no randomized controlled trials have been performed. A few studies have shown objective evidence that TENS may modulate or suppress pain signals in

729-447: A positive outcome. For people with recent-onset pain i.e. , fewer than three months, such as pain associated with surgery, trauma, and medical procedures, TENS may be better than placebo in some cases. The evidence of benefit is very weak, though. There is some evidence to support a benefit of using TENS in chronic musculoskeletal pain. Results from a task force on neck pain in 2008 found no clinically significant benefit of TENS for

810-554: A triangular field, which is named the lateral grey column . It comprises three different types of neurons, two types of lower motor neuron – large alpha motor neurons , and medium gamma motor neurons , and small neurons thought to be interneurons . These neurons differ in both their morphology and in their patterns of connectivity. They are organized in the same manner as the muscles they innervate. Alpha motor neurons are lower motor neurons that innervate extrafusal muscle fibers to generate force at neuromuscular junctions at

891-415: Is "best avoided" in patients with pacemakers or implantable cardioverter-defibrillators (ICDs). They add that "there is no consensus and it may be possible to safely deliver these modalities in a proper setting with device and patient monitoring", and recommend further research. The review found several reports of ICDs administering inappropriate treatment due to interference with TENS devices, but notes that

SECTION 10

#1733085431797

972-469: Is a common condition where there is a frequent feeling of needing to urinate to a degree that it negatively affects a person's life. The frequent need to urinate may occur during the day, at night , or both. Loss of bladder control ( urge incontinence ) may occur with this condition. This condition is also sometimes characterized by a sudden and involuntary contraction of the bladder muscles, in response to excitement or anticipation. This in turn leads to

1053-523: Is a tremor-customized therapy, based on the patient's measured tremor frequency, and is delivered transcutaneously to the median and radial nerves of a patient's wrist. The patient specific TAPS stimulation is determined through a calibration process performed by the accelerometer and microprocessor on the device. The Cala ONE delivers TAPS in a wrist-worn device that is calibrated to treat tremor symptoms. Cala ONE received de novo FDA clearance in April 2018 for

1134-594: Is almost entirely made up of interneurons which can be further divided by their morphology. The four main morphological classes, based on the shape of their dendritic structure, are islet, central, vertical, and radial cells. The interneurons can also be divided by their function: excitatory or inhibitory. The excitatory interneurons release glutamate as their main neurotransmitter and the inhibitory interneurons use GABA and/or glycine as their main neurotransmitter. The neurons of this layer are only C fibers and contain almost no myelin . These laminae are also known as

1215-524: Is also a good diagnostic aid. The amount of urine passed during each urination is relatively small. Pain while urinating suggests that there is a problem other than overactive bladder. Specific treatment is not always required. If treatment is desired pelvic floor exercises , bladder training , and other behavioral methods are initially recommended. Weight loss in those who are overweight , decreasing caffeine consumption, and drinking moderate fluids, can also have benefits. Medications, typically of

1296-665: Is also done in the sacrum . Systematic review studies have shown limited evidence on the effectiveness, and more quality research is needed. A major trial found that in a care home context transcutaneous posterior tibial nerve stimulation did not improve urinary incontinence . TENS has been extensively used in non-odontogenic orofacial pain relief. In addition, TENS and ultra low frequency-TENS (ULF-TENS) are commonly employed in diagnosis and treatment of temporomandibular joint dysfunction (TMD). Further clinical studies are required to determine its efficacy. A wearable neuromodulation device that delivers electrical stimulation to nerves in

1377-429: Is also known as a partially layered structure because only laminae I and II are well defined. The column can also be separated by nociceptive and non-nociceptive senses. Laminae I and II are important in nociception, laminae III and IV are not involved nociception, and lamina V is involved in both nociception and non-nociception. The function of the spinal dorsal horn is to process and integrate sensory information from

1458-418: Is also known as the marginal nucleus of spinal cord . The majority of posterior column projection neurons are located in lamina I, however most neurons in this layer are interneurons. The main areas these neurons innervate are the caudal ventrolateral medulla (CVLM), the nucleus of the solitary tract (NTS), the lateral parabrachial area (LPb), the periaqueductal grey matter (PAG), and certain regions in

1539-494: Is also known as the neck of the posterior column and receives information from mechanoreceptors and danger information from nociceptors. It has different neurons in different regions. In the medial region it contains medium-sized triangular neurons and the lateral region contains medium-sized multipolar neurons. This lamina is only found in the cervical and lumbar regions of the spinal cord. It receives afferent input from muscle fibers and joints. The lateral grey column , or

1620-440: Is broad and of a rounded or quadrangular shape. Its posterior part is termed the base, and its anterior part the head, but these are not differentiated from each other by any well-defined constriction. It is separated from the surface of the spinal cord by a layer of white substance which is traversed by the bundles of the anterior nerve roots. In the thoracic region, the posterolateral part of the anterior column projects laterally as

1701-417: Is damaged, or are frail. The use of TENS is likely to be less effective on areas of numb skin or decreased sensation due to nerve damage. It may also cause skin irritation due to the inability to feel currents until they are too high. There is an unknown level of risk when placing electrodes over an infection (possible spreading due to muscle contractions), but cross contamination with the electrodes themselves

SECTION 20

#1733085431797

1782-543: Is estimated to occur in 7–27% of men and 9–43% of women. It becomes more common with age. Some studies suggest that the condition is more common in women, especially when associated with loss of bladder control. Economic costs of overactive bladder were estimated in the United States at US$ 12.6 billion and 4.2 billion Euro in 2000. Overactive bladder is characterized by a group of four symptoms: urgency, urinary frequency, nocturia , and urge incontinence. Urge incontinence

1863-426: Is expected that OAB will become more common in the future as the average age of people living in the developed world is increasing. However, a recent Finnish population-based survey suggested that the number of people affected had been largely overestimated due to methodological shortcomings regarding age distribution and low participation (in earlier reports). It is suspected, then, that OAB affects approximately half

1944-436: Is important that the clinician and the person with overactive bladder both reach a consensus on the term, 'urgency.' Some common phrases used to describe OAB include, 'When I've got to go, I've got to go,' or 'When I have to go, I have to rush, because I think I will wet myself.' Hence the term, 'fear of leakage,' is an important concept to people. The cause of OAB is usually unclear, and indeed there may be multiple causes. It

2025-449: Is made primarily on the person's signs and symptoms and by ruling out other possible causes such as an infection. Urodynamics , a bladder scope , and ultrasound are generally not needed. Additionally, urine culture may be done to rule out infection. The frequency/volume chart may be maintained and cystourethroscopy may be done to exclude tumor and kidney stones . If there is an underlying metabolic or pathologic condition that explains

2106-440: Is made up of alpha motor neurons , gamma motor neurons , and small neurons thought to be interneurons . It affects the skeletal muscles . The posterior grey column receives several types of sensory information regarding touch and sensation from receptors in the skin, bones, and joints, including fine touch , proprioception , and vibration . It contains the cell bodies of second-order sensory neurons and their synapses with

2187-441: Is not absolute; one study suggested that many classified as "dry" were actually "wet" and that people with no history of any leakage may have had other syndromes. OAB is distinct from stress urinary incontinence , but when they occur together, the condition is usually known as mixed incontinence. The usual first suggested treatment for a person with overactive bladder is a combination of lifestyle changes, exercises to strengthen

2268-563: Is not present in the "dry" classification. Urgency is considered the hallmark symptom of OAB, but there are no clear criteria for what constitutes urgency and studies often use other criteria. Urgency is currently defined by the International Continence Society (ICS), as of 2002, as "Sudden, compelling desire to pass urine that is difficult to defer." The previous definition was "Strong desire to void accompanied by fear of leakage or pain." The definition does not address

2349-438: Is of greater concern. There are several anatomical locations where TENS electrodes are contraindicated : TENS used across an artificial cardiac pacemaker or other indwelling stimulator, including across its leads, may cause interference and failure of the implanted device. Serious accidents have been recorded in cases when this principle was not observed. A 2009 review in this area suggests that electrotherapy, including TENS,

2430-412: Is often associated with overactivity of the detrusor urinae muscle , a pattern of bladder muscle contraction observed during urodynamics . It is also possible that the increased contractile nature originates from within the urothelium and lamina propria, and abnormal contractions in this tissue could stimulate dysfunction in the detrusor or whole bladder. If bladder spasms occur or there is no urine in

2511-402: Is required. Non-pharmacological treatment options for people experiencing pain caused by cancer are much needed, however, it is not clear from the weak studies that have been published if TENS is an effective approach. Percutaneous and transcutaneous electrical nerve stimulation in the tibial nerve have been used in the treatment of overactive bladder and urinary retention . Sometimes it

Transcutaneous electrical nerve stimulation - Misplaced Pages Continue

2592-486: Is the target for some spasmolytic medications. Norepinephrine release here, (as induced by cyclobenzaprine ) reduces spasms by innervation (reducing nerve activity) of alpha motor neurons via interaction with gamma fibers . The posterior grey column , also known as the posterior (or dorsal) horn of spinal cord, is subdivided into six layers known as Rexed laminae , based on the type of sensory information sent to each section. The other four laminae are located in

2673-489: Is unknown. Risk factors include obesity, caffeine, and constipation . Poorly controlled diabetes , poor functional mobility , and chronic pelvic pain may worsen the symptoms. People often have the symptoms for a long time before seeking treatment and the condition is sometimes identified by caregivers. Diagnosis is based on a person's signs and symptoms and requires other problems such as urinary tract infections or neurological conditions to be excluded. Uroflowmetry

2754-541: The anti-muscarinic type, are only recommended if other measures are not effective. They are no more effective than behavioral methods; however, they are associated with side effects, particularly in older people. Some non-invasive electrical stimulation methods appear effective while they are in use. Injections of botulinum toxin into the bladder is another option. Urinary catheters or surgery are generally not recommended. A diary to track problems can help determine whether treatments are working. Overactive bladder

2835-427: The limbic system and tell the body to react to the danger stimulus (i.e. removing a hand from a hot stove). These neurons have larger receptive fields because the emotional reaction to most pain stimuli is similar. [REDACTED] This article incorporates text in the public domain from page 753 of the 20th edition of Gray's Anatomy (1918) Overactive bladder Overactive bladder ( OAB )

2916-436: The nucleus proprius and contain a much smaller density of neurons than lamina II. There are projection neurons scattered throughout these layers. Mechanosensitive A beta fibers terminate in these layers. The layers receive input from lamina II and also control pain, temperature, and crude touch. C fibers that control nociception and temperature and sensory information from mechanoreceptors are relayed here. This lamina

2997-481: The peripheral nervous system . It receives inputs from primary afferent fibers and modulatory systems, and it projects to higher brain centers and motor neurons . The dorsal horn circuitry is involved in various aspects of sensory processing, including discrimination, integration, and modulation of nociceptive and non-nociceptive signals. Dysfunction of the dorsal horn circuitry has been implicated in chronic pain conditions and other neurological disorders. Lamina I

3078-492: The prevention of migraine attacks . The Cefaly device was found effective in preventing migraine attacks in a randomized sham-controlled trial. This was the first TENS device the FDA approved for pain prevention, as opposed to pain suppression. A study performed on healthy human subjects demonstrates that repeated application of TENS can generate analgesic tolerance within five days, reducing its efficacy. The study noted that TENS causes

3159-440: The pseudounipolar first-order sensory neurons (whose cell bodies are located within the sensory ganglia (a.k.a. dorsal root ganglia) ). The lateral grey column is only present in the thoracic region and upper lumbar segments (T1-L2). It contains preganglionic cell bodies of the autonomic nervous system and sensory relay neurons. The anterior grey column , (also known as the anterior horn of spinal cord and anterior cornu)

3240-399: The thalamus . The CVLM receives nociceptive and cardiovascular responses. The NTS receives cardio-respiratory inputs and affects reflex tachycardia from noxious stimulation. The LPb projects to the amygdala and hypothalamus and is involved in the emotional response to pain. The PAG develops ways to deal with pain and is a main target of analgesics . It projects to other parts of

3321-454: The A beta fibers. The C fibers are not myelinated and therefore slower. C fibers that carry nociceptive signals can be divided into two types: fibers that contain neuropeptides , like substance P , and fibers that do not contain neuropeptides. The two types terminate in very different areas. Non-peptidergic C fibers are linked to the skin, where they innervate the epidermis while peptidergic C fibers innervate other tissues and deeper parts of

Transcutaneous electrical nerve stimulation - Misplaced Pages Continue

3402-555: The International Consultation on Incontinence Questionnaire (ICIQ). OAB causes similar symptoms to some other conditions such as urinary tract infection (UTI), bladder cancer , and benign prostatic hyperplasia (BPH). Urinary tract infections often involve pain and hematuria (blood in the urine) which are typically absent in OAB. Bladder cancer usually includes hematuria and can include pain, both not associated with OAB, and

3483-442: The authors downgraded their confidence in the results by two levels, to low-certainty. Grey columns The grey columns are three regions of the somewhat ridge-shaped mass of grey matter in the spinal cord . These regions present as three columns: the anterior grey column , the posterior grey column , and the lateral grey column , all of which are visible in cross-section of the spinal cord. The anterior grey column

3564-445: The bladder and causes urine to pass out of it. Both invasive and non-invasive electrical stimulation procedures may be used to treat overactive bladder. If non-invasive and pharmacological approaches are not helpful, some people may be eligible for a surgical procedure to treat overactive bladder. Surgical options may include urinary diversion , sacral neuromodulation , or augmentation cystoplasty. One surgical intervention, called

3645-420: The bladder wall can suppress involuntary bladder contractions by blocking nerve signals and may be effective for up to 9 months. The growing knowledge of pathophysiology of overactive bladder fueled a huge amount of basic and clinical research in this field of pharmacotherapy. Overactive bladder may be treated with electrical stimulation, which aims to reduce the contractions of the muscle that tenses around

3726-569: The brain. A randomized controlled trial in 2017 shown that sensory ULF -TENS applied on the skin proximally to trigeminal nerve , reduced the effect of acute mental stress assessed by heart rate variability (HRV). Further high quality studies are required to determine the effectiveness of TENS for treating dementia. A head-mounted TENS device called Cefaly was approved by the United States Food and Drug Administration (FDA), in March 2014, for

3807-411: The brain. One used evoked cortical potentials to show that electric stimulation of peripheral A-beta sensory fibers reliably suppressed A-delta fiber nociceptive (pain perception) processing. Two other studies used functional magnetic resonance imaging (fMRI): one showed that high-frequency TENS produced a decrease in pain-related cortical activations in patients with carpal tunnel syndrome , while

3888-405: The brainstem. The nuclei of the thalamus affect sensory and motivational aspects of pain. The neurons of this lamina can be distinguished by their morphology as pyramidal , spindle , or multipolar . This layer is also known as the substantia gelatinosa of Rolando and has the highest density of neurons. These neurons mediate the activity of nociceptive and temperature afferent fibers. It

3969-669: The common symptoms of OAB (urgency, frequency, and nocturia) may be absent. BPH frequently includes symptoms at the time of voiding as well as sometimes including pain or hematuria, and all of these are not usually present in OAB. Diabetes insipidus causes high frequency and volume, though not necessarily urgency. There is some controversy about the classification and diagnosis of OAB. Some sources classify overactive bladder into two different variants: "wet" (i.e., an urgent need to urinate with involuntary leakage) or "dry" (i.e., an urgent need to urinate but no involuntary leakage). Wet variants are more common than dry variants. The distinction

4050-439: The condition and enhance the effectiveness of other treatment approaches. Most patients are not able to eliminate incontinence and other symptoms of OAB with lifestyle and behavioral modifications alone. However, numerous studies have demonstrated that these therapies are effective in improving quality of life, and some data shows that they increase the likelihood that medications can keep the OAB under control. Medications are

4131-472: The dorsal horn circuitry has been implicated in chronic pain conditions and other neurological disorders. Laminae I and II receive information from afferent neurons that sense nociception, temperature, and itching, laminae III and IV are sent information from neurons that sense mechanical pressure, and laminae V and VI are sent information from proprioceptors. It is known to be the primary relay point for haptic and nociceptive messages. The posterior horn

SECTION 50

#1733085431797

4212-413: The drainage bag when a catheter is in place, the catheter may be blocked by blood, thick sediment, or a kink in the catheter or drainage tubing. Sometimes spasms are caused by the catheter irritating the bladder, prostate or penis . Such spasms can be controlled with medication such as butylscopolamine , although most people eventually adjust to the irritation and the spasms go away. Diagnosis of OAB

4293-639: The early 2000s cosmodic devices. Each of these device types uses the fundamental technique of reading electrical signals in the skin, analyzing the signals, and returning therapeutic electrical pulses into the nerves. He terms the TENS devices first generation electronic pain relief devices, scenar devices second generation devices, cosmodic devices as third generation devices, and the D.O.V.E. (Device Organizing Vital Energy) device as an advanced second generation device which automatically incorporates some cosmodic therapeutic features. As reported, TENS has different effects on

4374-420: The electrodes and mild redness of the skin ( erythema ). Some people also report that they dislike the sensation associated with TENS. The TENS device acts to stimulate the sensory nerves and a small portion of the peripheral motor nerves; the stimulation causes multiple mechanisms to trigger and manage the sense of pain in a patient. TENS operates by two main mechanisms: it stimulates competing sensory neurons at

4455-424: The immediacy of the urge to void and has been criticized as subjective. Urinary frequency is considered abnormal if the person urinates more than eight times in a day. This frequency is usually monitored by having the person keep a voiding diary where they record urination episodes. The number of episodes varies depending on sleep, fluid intake, medications, and up to seven is considered normal if consistent with

4536-447: The involuntary loss of urine occurring for no apparent reason while feeling urinary urgency as discussed above. Like frequency, the person can track incontinence in a diary to assist with diagnosis and management of symptoms. Urge incontinence can also be measured with pad tests, and these are often used for research purposes. Some people with urge incontinence also have stress incontinence and this can complicate clinical studies. It

4617-441: The lateral grey column. MSA has been shown to reduce the cell count in the lateral column by over 50%. The posterior column has a prominent role in the pain system , it is the first central relay in the nociceptive pathway. The first-order afferent neuron carries sensory information to the second order neuron in the dorsal horn. The axon of the second order neuron, if it is a projection neuron and not an interneuron, then goes to

4698-523: The lateral horn of spinal cord, is part of the sympathetic nervous system and receives input from brain stem , organs, and hypothalamus . The lateral column is only present in the thoracic region and upper lumbar segments. The lateral grey column contains preganglionic cell bodies of the autonomic nervous system and sensory relay neurons. Neurons in the anterior column have been shown to be affected by amyotrophic lateral sclerosis (ALS). The number of large alpha motor neurons and medium gamma motor neurons

4779-452: The muscles that control urination. Fluid management, which focuses on avoiding excessive caffeine and alcohol intake, is advised to reduce the rate at which the bladder fills and minimize irritation to the bladder. Weight management and maintaining a healthy diet contribute to overall bladder health, especially when weight loss is able to reduce abdominal compression of the bladder. Adopting these behavioral and lifestyle changes can often improve

4860-518: The nervous system. Today many people confuse TENS with electrical muscle stimulation (EMS). EMS and TENS devices look similar, with both using long electric lead wires and electrodes. TENS is for blocking pain, where EMS is for stimulating muscles. Beginning in the late 1970s, in the USSR as part of their space program further research was conducted into electronic pain reduction devices. Dr. Alexander Karasev developed scenar (or skenar) devices, and later in

4941-485: The other factors. Nocturia is a symptom where the person complains of interrupted sleep because of an urge to void and, like the urinary frequency component, is affected by similar lifestyle and medical factors. Individual waking events are not considered abnormal, one study in Finland established two or more voids per night as affecting quality of life. Urge incontinence is a form of urinary incontinence characterized by

SECTION 60

#1733085431797

5022-489: The other showed that low-frequency TENS decreased shoulder impingement pain and modulated pain-induced activation in the brain. Early studies found that TENS "has been shown not to be effective in postoperative and labour pain." These studies also had questionable ability to truly blind the patients. However, more recent studies have shown that TENS was "effective for relieving labour pain, and they are well considered by pregnant participants." One study also showed that there

5103-503: The other two grey columns in the spinal cord. The function of the spinal dorsal horn is to process and integrate sensory information from the peripheral nervous system . It receives inputs from primary afferent fibers and modulatory systems, and it projects to higher brain centers and motor neurons . The dorsal horn circuitry is involved in various aspects of sensory processing, including discrimination, integration, and modulation of nociceptive and non-nociceptive signals. Dysfunction of

5184-593: The pain perception gate, and it stimulates the opiate response. The mechanism that will be used varies with the type of device. The table below lists the types of devices: Electrical stimulation for pain control was used in ancient Rome , in AD 63. It was reported by Scribonius Largus that pain was relieved by standing on an electrical fish at the seashore. In the 16th through the 18th centuries various electrostatic devices were used for headache and other pains. Benjamin Franklin

5265-525: The patients said they received so much relief from the TENS itself that they never returned for the implant. A number of companies began manufacturing TENS units after the commercial success of the Medtronic device became known. The neurological division of Medtronic, founded by Don Maurer, Ed Schuck and Charles Ray, developed a number of applications for implanted electrical stimulation devices for treatment of epilepsy, Parkinson's disease, and other disorders of

5346-549: The person's pelvic floor, and manage how much the person drinks and when during the day ("fluid management"). Patients who continue to experience incontinence episodes, or who express a desire for medication along with therapy, may be treated with several classes of drugs, notably anticholinergics . Patients who prove resistant to medications and therapy may then be treated with neurological interventions, such as treatment with botulinum toxin (Botox) and other minimally-invasive surgical procedures, such as sacral neuromodulation . As

5427-450: The release of endogenous opioids , and that the analgesia is likely due to opioid tolerance mechanisms. The pain reduction ability of TENS is unconfirmed by sufficient randomized controlled trials so far. One meta-analysis of several hundred TENS studies concluded that there was a significant overall reduction of pain intensity due to TENS, but there were too few participants and controls to be entirely certain of their validity. Therefore,

5508-492: The reports on pacemakers are mixed: some non-programmable pacemakers were inhibited by TENS, but others were unaffected or auto-reprogrammed. TENS should be used with caution on people with epilepsy or on pregnant women; do not use over area of the uterus, as the effects of electrical stimulation on the developing fetus are not known. Overall, TENS has been found to be safe compared with pharmaceutical medications for treating pain. Potential side effects include skin itching near

5589-530: The rest of their lives. A minority of age-related OAB cases may be cured or indefinitely suppressed by medications and behavioral modification. If the OAB is due to a different condition, such as a urinary tract infection , then symptoms should resolve after the underlying problem has been treated. Earlier reports estimated that about one in six adults in the United States and Europe had OAB. The number of people affected with OAB increases with age, thus it

5670-443: The skin. There are two main types of nociceptive signals: sensory and affective. Sensory nociceptive signals provide information about what kind of stimulus (heat, mechanical, etc.) is affecting the body and also indicates where on the body the stimulus is. Sensory nociceptive neurons have a small receptive field to help pinpoint the exact location of a stimulus. Affective nociceptive signals affect emotions. These signals go to

5751-584: The small neurons in the anterior column is not well understood. Their effects can be both excitatory and inhibitory . They are suspected to be interneurons and have been shown to reduce in size but not numbers with age. Clinical significance It is these cells that are affected in the following diseases, – amyotrophic lateral sclerosis , spinal and bulbar muscular atrophy , Charcot–Marie–Tooth disease , progressive muscular atrophy , all spinal muscular atrophies , poliomyelitis , and West Nile virus . Pharmacological interaction The anterior grey column

5832-600: The start of a muscle contraction . They have large cell bodies and receive proprioceptive input. They have been shown to reduce in population, but not in size with age. Damage to these cell bodies can lead to severe muscle weakness and loss of reflexes, and is also associated with ALS . Gamma motor neurons innervate intrafusal muscle fibers that control the sensitivity of muscle spindles to stretch. They have smaller cell bodies than alpha motor neurons and do not receive proprioceptive input. They have been shown to reduce in numbers but not size with age. The physiology of

5913-799: The symptoms, the symptoms may be considered part of that disease and not OAB. Psychometrically robust self-completion questionnaires are generally recognized as a valid way of measuring a person's signs and symptoms, but there does not exist a single ideal questionnaire. These surveys can be divided into two groups: general surveys of lower urinary tract symptoms and surveys specific to overactive bladder. General questionnaires include: American Urological Association Symptom Index (AUASI), Urogenital Distress Inventory (UDI), Incontinence Impact Questionnaire (IIQ), and Bristol Female Lower Urinary Tract Symptoms (BFLUTS). Overactive bladder questionnaires include: Overactive Bladder Questionnaire (OAB-q), Urgency Questionnaire (UQ), Primary OAB Symptom Questionnaire (POSQ), and

5994-425: The third order neuron in the thalamus . The thalamus is known as the "gateway to the cortex". The third order neuron then goes to the cerebral cortex . The afferent neurons are either A fibers or C fibers. A fibers are myelinated allowing for faster signal conduction. Among these there are A beta fibers which are faster and carry information about non-painful touch and A delta fibers which are slower and thinner than

6075-408: The transient relief of hand tremors in adults with essential tremor and is currently marketed as Cala Trio. People who have implanted electronic medical devices including pacemakers and cardiodefibrillators are not suggested to use TENS. In addition, caution should be taken before using TENS in those who are pregnant, have epilepsy, have an active malignancy, have deep vein thrombosis , have skin that

6156-474: The treatment of neck pain when compared to placebo. A 2010 review did not find evidence to support the use of TENS for chronic low back pain . Another study examining knee osteoarthritis patients found that TENS demonstrated efficacy and a better safety profile relative to weak opiates. Given the age, comorbidity frequency, tendency toward polypharmacy , and sensitivity to adverse reactions among individuals most frequently reporting osteoarthritis, TENS could be

6237-532: The wrist is now available by prescription. Worn around the wrist, it acts as a non-invasive treatment for those living with essential tremor . The stimulator has electrodes that are placed circumferentially around a patient's wrist. Positioning the electrodes on generally opposing sides of the target nerve can result in improved stimulation of the nerve. In clinical trials reductions in hand tremors were reported following noninvasive median and radial nerve stimulation. Transcutaneous afferent patterned stimulation (TAPS)

6318-414: Was a proponent of this method for pain relief. In the 19th century a device called the electreat, along with numerous other devices were used for pain control and cancer cures. Only the electreat survived into the 20th century, but was not portable, and had limited control of the stimulus. Development of the modern TENS unit is generally credited to C. Norman Shealy . The first modern, patient-wearable TENS

6399-430: Was a significant change in laboring individuals' time to request analgesia such as an epidural. The group with the TENS waited five additional hours relative to those without TENS. Both groups were satisfied with the pain relief that they had from their choices. No maternal, infant, or labor problems were noted. There is tentative evidence that TENS may be helpful for treating pain from dysmenorrhoea, however further research

6480-522: Was greatly reduced and the number of small neurons was either slightly or greatly reduced depending on the type of ALS. Muscular atrophy has also been shown to have an effect on neurons of the anterior column. A large loss of large alpha motor neurons, medium gamma motor neurons, and small neurons was recorded in cases of muscular atrophy. Damage to the lateral column can result in Horner's syndrome . Multiple system atrophy (MSA), has also been linked to

6561-422: Was patented in the United States in 1974. It was initially used for testing the tolerance of chronic pain patients to electrical stimulation before implantation of electrodes in the spinal cord dorsal column . The electrodes were attached to an implanted receiver, which received its power from an antenna worn on the surface of the skin. Although intended only for testing tolerance to electrical stimulation, many of

#796203